Group One Trading, L.P. A Tyr Pharma Inc Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$2.79 - $4.15 $24,588 - $36,573	8,813 Added 156.04%	14,461 $43,000
Q2 2022 Aug 11, 2022	BUY	$2.63 - $5.61 $14,854 - $31,685	5,648 New	5,648 $16,000
Q4 2021 Feb 11, 2022	SELL	$7.29 - $9.5 $14,740 - $19,209	-2,022 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.22 - $12.48 $8,351 - $24,697	1,979 Added 4602.33%	2,022 $18,000
Q3 2019 Nov 12, 2019	BUY	$2.8 - $5.46 $120 - $234	43 New	43 $0

37.2M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.